Genomics of Primary Sclerosing Cholangitis (PSC)
P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.
Sponsor: Mayo Clinic
Listed as NCT01161992, this observational or N/A phase trial focuses on Primary Sclerosing Cholangitis (PSC) and remains completed. Sponsored by Mayo Clinic, it has been updated 20 times since 2002, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 15 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Feb 2023 — Apr 2024 [monthly]
Active Not Recruiting
-
Feb 2022 — Feb 2023 [monthly]
Active Not Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Jan 2019 — Jan 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Phase: PHASE1 → NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE1
First recorded
Mar 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .